16 November 2012

Investigators to Present Preliminary Adaptimmune’s Findings for Gene Engineered T Cells in Myeloma

Adaptimmune announces the publication of dual abstracts in today’s issue of the Journal Blood, which report preliminary results from an early phase study using patients’ own T cells that have been genetically altered to attack multiple myeloma (MM) cells.  Lead investigators for the study will be presenting the data on December 10th at the annual meeting of the American Society of Hematology (ASH).

Please click here for full Press Release

« Back to News